Similar Articles
301 Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
302 Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
303 Preoperative prediction of microvascular invasion in hepatocellular carcinoma using ultrasound features including elasticity
304 Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
305 Prognostic model of hepatocellular carcinoma based on cancer grade
306 Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature
307 Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis
308 Risk factors for stroke recurrence in young patients with first-ever ischemic stroke: A meta-analysis
309 Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma
310 Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA